Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-12 Sale | 2024-03-13 5:22 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $41.95 | $839,100 | 244,484 (Direct) | View |
2024-02-27 Sale | 2024-02-28 6:49 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $39.75 | $794,923 | 224,714 (Direct) | View |
2024-01-16 Sale | 2024-01-18 4:07 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $36 | $720,000 | 211,681 (Direct) | View |
2023-12-12 Sale | 2023-12-13 7:48 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $40.01 | $800,262 | 251,681 (Direct) | View |
2023-11-14 Sale | 2023-11-16 4:18 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $39.43 | $788,670 | 179,269 (Direct) | View |
2023-10-17 Sale | 2023-10-17 7:28 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $36.52 | $365,200 | 193,010 (Direct) | View |
2023-09-19 Sale | 2023-09-19 4:09 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $39.1 | $390,980 | 203,010 (Direct) | View |
2023-08-29 Sale | 2023-08-31 5:35 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $42.69 | $1,280,730 | 983,666 (Direct) | View |
2023-08-22 Sale | 2023-08-23 5:08 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $42.41 | $424,070 | 218,590 (Direct) | View |
2023-08-15 Sale | 2023-08-17 5:29 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $43.49 | $1,304,820 | 1,073,666 (Direct) | View |
2023-08-11 Sale | 2023-08-15 4:04 pm | HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director | 20,000 | $43.73 | $874,520 | 20,503 (Direct) | View |
2023-07-25 Sale | 2023-07-27 4:03 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $43.09 | $1,292,750 | 1,163,666 (Direct) | View |
2023-07-18 Sale | 2023-07-19 4:10 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $40.43 | $404,300 | 261,868 (Direct) | View |
2023-06-21 Sale | 2023-06-22 6:20 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $36 | $360,000 | 159,416 (Direct) | View |
2023-04-18 Sale | 2023-04-19 6:07 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $36 | $360,000 | 169,416 (Direct) | View |
2023-02-27 Sale(A) | 2023-04-19 6:01 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,984 | $49.55 | $147,854 | 179,416 (Direct) | View |
2023-03-07 Sale | 2023-03-09 5:04 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $43.82 | $1,314,550 | 653,666 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-13 Exercise | 2024-03-13 5:22 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 3,551 | $8.11 | 244,484 (Direct) | View |
2024-03-12 Exercise | 2024-03-13 5:22 pm | N/A 2027-02-22 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 244,484 (Direct) | View |
2024-03-12 Exercise | 2024-03-13 5:22 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 16,449 | $12.07 | 244,484 (Direct) | View |
2024-02-28 Exercise | 2024-02-28 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 7,471 | $8.11 | 224,714 (Direct) | View |
2024-02-28 Exercise | 2024-02-28 6:49 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 7,471 | $0 | 224,714 (Direct) | View |
2024-02-23 Option Award | 2024-02-27 5:12 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 38,659 | $0 | 38,659 (Direct) | View |
2024-02-23 Option Award | 2024-02-27 5:08 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 57,109 | $0 | 57,109 (Direct) | View |
2024-02-23 Option Award | 2024-02-27 5:05 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 54,473 | $0 | 54,473 (Direct) | View |
2024-02-23 Option Award | 2024-02-27 5:01 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 182,746 | $0 | 182,746 (Direct) | View |
2024-02-16 Tax Withholding | 2024-02-20 6:59 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,257 | $36.1 | 194,100 (Direct) | View |
2024-02-16 Exercise | 2024-02-20 6:59 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,376 | $0 | 194,100 (Direct) | View |
2024-02-16 Tax Withholding | 2024-02-20 6:55 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 2,577 | $36.1 | 26,068 (Direct) | View |
2024-02-16 Exercise | 2024-02-20 6:55 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 4,796 | $0 | 26,068 (Direct) | View |
2024-02-16 Tax Withholding | 2024-02-20 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,601 | $36.1 | 41,653 (Direct) | View |
2024-02-16 Exercise | 2024-02-20 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 10,422 | $0 | 41,653 (Direct) | View |
2024-02-16 Tax Withholding | 2024-02-20 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 20,362 | $36.1 | 769,386 (Direct) | View |
2024-02-16 Exercise | 2024-02-20 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 37,884 | $0 | 769,386 (Direct) | View |
2024-02-15 Option Award | 2024-02-16 5:47 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,479 | $0 | 167,354 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 5:47 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,040 | $35.91 | 167,354 (Direct) | View |
2024-02-15 Exercise | 2024-02-16 5:47 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 3,386 | $0 | 167,354 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 5:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 686 | $35.91 | 11,913 (Direct) | View |
2024-02-15 Exercise | 2024-02-16 5:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 1,254 | $0 | 11,913 (Direct) | View |
2024-02-15 Option Award | 2024-02-16 5:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 32,781 | $0 | 672,314 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 5:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 24,655 | $35.91 | 672,314 (Direct) | View |
2024-02-15 Exercise | 2024-02-16 5:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 13,092 | $0 | 672,314 (Direct) | View |
2024-02-10 Tax Withholding | 2024-02-13 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,901 | $35.49 | 157,143 (Direct) | View |
2024-02-10 Exercise | 2024-02-13 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,133 | $0 | 157,143 (Direct) | View |
2024-02-10 Tax Withholding | 2024-02-13 4:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 1,477 | $35.49 | 10,091 (Direct) | View |
2024-02-10 Exercise | 2024-02-13 4:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2,502 | $0 | 10,091 (Direct) | View |
2024-02-10 Tax Withholding | 2024-02-13 4:12 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 16,943 | $35.49 | 638,004 (Direct) | View |
2024-02-10 Exercise | 2024-02-13 4:12 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 31,281 | $0 | 638,004 (Direct) | View |
2024-01-16 Exercise | 2024-01-18 4:07 pm | N/A 2027-02-22 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 211,681 (Direct) | View |
2024-01-16 Exercise | 2024-01-18 4:07 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $12.07 | 211,681 (Direct) | View |
2024-01-03 Exercise | 2024-01-05 4:04 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 7,611 | $0 | 24,683 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-05 4:04 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 2,957 | $35.78 | 24,683 (Direct) | View |
2023-12-12 Exercise | 2023-12-13 7:48 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,533 | $13.81 | 251,681 (Direct) | View |
2023-12-12 Exercise | 2023-12-13 7:48 pm | N/A 2025-02-04 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 251,681 (Direct) | View |
2023-12-12 Exercise | 2023-12-13 7:48 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 11,467 | $12.07 | 251,681 (Direct) | View |
2023-11-14 Exercise | 2023-11-16 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 18,292 | $13.81 | 179,269 (Direct) | View |
2023-11-14 Exercise | 2023-11-16 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 1,708 | $16.78 | 179,269 (Direct) | View |
2023-11-14 Exercise | 2023-11-16 4:18 pm | N/A 2025-02-04 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 179,269 (Direct) | View |
2023-10-17 Exercise | 2023-10-17 7:28 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $19.98 | 193,010 (Direct) | View |
2023-10-17 Exercise | 2023-10-17 7:28 pm | N/A 2030-02-10 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 193,010 (Direct) | View |
2023-09-19 Exercise | 2023-09-19 4:09 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $19.98 | 203,010 (Direct) | View |
2023-09-19 Exercise | 2023-09-19 4:09 pm | N/A 2030-02-10 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 203,010 (Direct) | View |
2023-08-29 Exercise | 2023-08-31 5:35 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 983,666 (Direct) | View |
2023-08-22 Exercise | 2023-08-23 5:08 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,075 | $19.98 | 218,590 (Direct) | View |
2023-08-22 Exercise | 2023-08-23 5:08 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 1,925 | $18.41 | 218,590 (Direct) | View |
2023-08-22 Exercise | 2023-08-23 5:08 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 218,590 (Direct) | View |
2023-08-15 Exercise | 2023-08-17 5:29 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 1,073,666 (Direct) | View |
2023-07-25 Exercise | 2023-07-27 4:03 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 1,163,666 (Direct) | View |
2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $18.41 | 261,868 (Direct) | View |
2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,825 | $8.11 | 261,868 (Direct) | View |
2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 7,175 | $13.81 | 261,868 (Direct) | View |
2023-07-18 Exercise | 2023-07-19 4:10 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 261,868 (Direct) | View |
2023-06-21 Exercise | 2023-06-22 6:20 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $18.41 | 159,416 (Direct) | View |
2023-06-21 Exercise | 2023-06-22 6:20 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 159,416 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:27 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 19,436 | $0 | 124,625 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:24 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Miyashita Akiko Moni Director | 19,436 | $0 | 25,642 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:21 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director | 19,436 | $0 | 198,375 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:19 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director | 19,436 | $0 | 58,481 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:16 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director | 19,436 | $0 | 20,624 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:14 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director | 19,436 | $0 | 51,874 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:12 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director | 19,436 | $0 | 51,657 (Direct) | View |
2023-05-05 Option Award | 2023-05-09 6:09 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | BIZZARI JEAN-PIERRE Director | 19,436 | $0 | 78,186 (Direct) | View |
2023-04-18 Exercise | 2023-04-19 6:07 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $18.41 | 169,416 (Direct) | View |
2023-04-18 Exercise | 2023-04-19 6:07 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 169,416 (Direct) | View |
2023-02-27 Exercise(A) | 2023-04-19 6:01 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,984 | $18.41 | 179,416 (Direct) | View |
2023-02-27 Exercise(A) | 2023-04-19 6:01 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,984 | $0 | 179,416 (Direct) | View |
2023-03-07 Exercise | 2023-03-09 5:04 pm | N/A 2024-01-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $14.66 | 653,666 (Direct) | View |